
               
               
               
                  DRUG INTERACTIONS
                  (The following interactions are from a published review and include reports concerning both oral and topical salicylate administration. The relationship of these
interactions to the use of Salicylic Acid 6% Foam is not known.)
I.    Due to the competition of salicylate with other drugs for binding to serum albumin, the following drug interactions may occur:
                  Drug                                                                Description of Interaction
Tolbutamide; Sulfonylureas                        Hypoglycemia potentiated
Methotrexate                                                  Decrease tubular reabsorption; clinical toxicity from methotrexate can result
Oral Anticoagulants                                       Increased bleeding
                  

                  
                     

                  
                  II.   Drugs changing salicylate levels by altering renal tubular reabsorption:
                  Drug                                        Description
Corticosteroids                      Decreases plasma salicylate level; tapering doses of steroids may promote salicylism
Ammonium Sulfate                Increases plasma salicylate level
                  

                  
                     

                  
                  
III.  Drugs with complicated interactions with salicylates:
Drug                                         Description
Heparin                                    Salicylate decreases platelet adhesivesness and interferes with hemostasis in 
                                                        heparin-treated patients
Pyrazinamide                            Inhibits pyrazinamide-induced hyperuricemia
Uricosuric Agents                    Effect of probenecid, sulfinpyrazone and phenylbutazone inhibited

               
               
            
         